Neurocrine Biosciences (NBIX) Shares Outstanding (Entity) (2010 - 2026)
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 214.24 Mn |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 200.98 Mn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn | 42.68 Mn |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | 101.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 101.60 Mn |
| Mar 31, 2026 | 100.60 Mn |
| Dec 31, 2025 | 100.10 Mn |
| Sep 30, 2025 | 99.70 Mn |
| Jun 30, 2025 | 99.00 Mn |
| Mar 31, 2025 | 99.00 Mn |
| Dec 31, 2024 | 99.40 Mn |
| Sep 30, 2024 | 101.20 Mn |
| Jun 30, 2024 | 100.90 Mn |
| Mar 31, 2024 | 100.60 Mn |
| Dec 31, 2023 | 98.70 Mn |
| Sep 30, 2023 | 98.20 Mn |
| Jun 30, 2023 | 97.60 Mn |
| Mar 31, 2023 | 97.50 Mn |
| Dec 31, 2022 | 96.50 Mn |
| Sep 30, 2022 | 96.10 Mn |
| Jun 30, 2022 | 95.60 Mn |
| Mar 31, 2022 | 95.50 Mn |
| Dec 31, 2021 | 94.90 Mn |
| Sep 30, 2021 | 94.80 Mn |